2c4f
From Proteopedia
Line 8: | Line 8: | ||
==About this Structure== | ==About this Structure== | ||
- | 2C4F is a | + | 2C4F is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with GLC, FUC, NAG, CA and GIL as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Coagulation_factor_VIIa Coagulation factor VIIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.21 3.4.21.21] Structure known Active Site: AC1. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2C4F OCA]. |
==Reference== | ==Reference== | ||
Line 35: | Line 35: | ||
[[Category: transmembrane]] | [[Category: transmembrane]] | ||
- | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 5 13:50:57 2007'' |
Revision as of 11:45, 5 November 2007
|
CRYSTAL STRUCTURE OF FACTOR VII.STF COMPLEXED WITH PD0297121
Overview
The activated factor VII/tissue factor complex (FVIIa/TF) is known to play, a key role in the formation of blood clots. Inhibition of this complex may, lead to new antithrombotic drugs. A fluoropyridine-based series of, FVIIa/TF inhibitors was discovered which utilized a diisopropylamino group, for binding in the S2 and S3 binding pockets of the active site of the, enzyme complex. In this series, an enhancement in binding affinity was, observed by substitution at the 5-position of the hydroxybenzoic acid, sidechain. An X-ray crystal structure indicates that amides at this, position may increase inhibitor binding affinity through interactions with, the S1'/S2' pocket.
About this Structure
2C4F is a Protein complex structure of sequences from [1] with GLC, FUC, NAG, CA and GIL as ligands. Active as Coagulation factor VIIa, with EC number 3.4.21.21 Structure known Active Site: AC1. Full crystallographic information is available from OCA.
Reference
The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex--Part 2., Kohrt JT, Filipski KJ, Cody WL, Cai C, Dudley DA, Van Huis CA, Willardsen JA, Narasimhan LS, Zhang E, Rapundalo ST, Saiya-Cork K, Leadley RJ, Edmunds JJ, Bioorg Med Chem Lett. 2006 Feb 15;16(4):1060-4. Epub 2005 Nov 11. PMID:16289811
Page seeded by OCA on Mon Nov 5 13:50:57 2007
Categories: Coagulation factor VIIa | Protein complex | Kohrt, J.T. | Zhang, E. | CA | FUC | GIL | GLC | NAG | Blood coagulation | Egf | Egf-like domain | Gla | Glycoprotein | Hydrolase | Hydroxylation | Lipoprotein | Palmitate | Protease | Receptor enzyme | Serine protease | Transmembrane